The Asia-Pacific OTC drug market is anticipated to grow at a CAGR of 7.9% during the forecast period. The market growth is attributed to the increasing shift of consumers towards self-medication, product innovation coupled with the focus of pharmaceutical companies to bring new products to the market. Further, the increasing healthcare expenditure, unhealthy dietary habits, […]
